Lv4
450 积分 2026-06-10 加入
Adalimumab-Induced Paradoxical Psoriasis Treated with Biologics Targeting the IL-17/IL-23 Axis in Patients with Hidradenitis Suppurativa
2个月前
已完结
Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis
2个月前
已完结
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
2个月前
已完结
Biologics-Induced Immunophenotypic Cross-Switching in Patients with Psoriasis and Atopic Dermatitis
2个月前
已完结
Secukinumab-Induced Severe Palmoplantar Psoriasis treated with Guselkumab: A Case Report
2个月前
已完结
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
2个月前
已完结
The incidence of hepatitis B reactivation in patients receiving ustekinumab: a systematic review and proportional meta-analysis
2个月前
已完结
The Incidence and Management of TNF‐α Inhibitor Induced Paradoxical Psoriasis in Children With Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis
2个月前
已完结
Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy
2个月前
已完结
Systematic review of TNFα-induced paradoxical psoriasis: Treatment outcomes of switching to alternative biologic therapies in inflammatory bowel disease patients
2个月前
已完结
皖公网安备34019202002308
